Sabin Vaccine Institute

?? New VARN Online Community Event! Mapping the Unvaccinated: Innovative Low and High-Tech Methods for Identifying Zero-Dose Children ?? Join us for an interactive, collaborative session where we will explore both low-tech (community volunteers) and high-tech (GIS mapping) strategies to identify zero-dose children. This session features expert speakers sharing their work in #Ethiopia and #Zambia followed by breakout room discussions designed to exchange ideas and strategies. ?? Date: March 20 ? Time: 7 - 8 a.m. ET ?? Speakers: Low-tech: Negussie Deyessa, PhD, MPH, MBBS & Filimona Bisrat, MBBS High-tech: Rohan Arambepola, PhD ?? To register, join the VARN Online Community: https://lnkd.in/eUkEFxHr Don't miss this opportunity to share your experiences and gain new insights into identifying zero-dose children! #ZeroDose #Vaccination #PublicHealth #GlobalHealth

"Measles-mumps-rubella (MMR) vaccination remains the most important tool for preventing measles." The Centers for Disease Control and Prevention issued a Health Advisory to notify clinicians, public health officials, and potential travelers about a measles outbreak in Texas and New Mexico, and offer guidance for prevention and monitoring amidst the resurgence of the highly contagious disease. #VaccinesWork https://lnkd.in/etMwRmiW

This #InternationalWomensDay, some of our Boost Community members shared what they find inspirational and impactful about women working in immunization. Hear their messages for women leading the way in the field. ??

Researchers in C?te d’Ivoire are using phage-based environmental surveillance alongside community-based serosurveillance to better understand typhoid transmission, estimate disease burden, and #TakeOnTyphoid. Read more ?? https://lnkd.in/exR4bbXN

?? Are you passionate about global health? Here at Sabin, we are an innovative, collaborative, and engaged team dedicated to improving lives through vaccination, and we're looking for others to join our mission. Check out our job listings to see if you might be a fit ? https://lnkd.in/es_FEpTs

Our work in Kenya to generate critical data on the use of oral cholera vaccine (OCV) is crucial as #ClimateChange and conflict are fueling a resurgence of #cholera in #Africa due to a combination of insufficient water, sanitation, and hygiene (#WASH) infrastructure, persistent funding gaps, and other challenges within the health system. Repost from SciDev.Net ?? https://lnkd.in/eBBcwuBA

Did you know that 95% of cervical cancer cases are caused by persistent untreated HPV infection in the cervix? This #InternationalHPVAwarenessDay learn more about HPV's connection to certain cancers and the efforts of the #GlobalHPVConsortium to increase #HPV vaccination awareness and uptake. ?? https://lnkd.in/ewejsSU9

?? Subscribe to our new quarterly newsletter, Sabin Vaccine Wire, and get the latest updates on our research and development efforts right in your inbox. Our first issue in 2025 goes out at the end of this month! ?? https://lnkd.in/e7wXc6t8

?? #VaccinesWork differently depending on the type of vaccine, the target disease, and the desired immune response. Infants, children, and needle-phobic adults also have different needs, and many factors must be considered when it comes to vaccine delivery. ?? New advancements like microneedle patches and high-density microarray patches aim to enhance efficacy, accessibility, and patient experience. ?? Of particular importance is reducing or eliminating the need for cold-chain transport and storage, which comes at a significant cost, particularly for low-and middle-income countries. Learn more ?? https://lnkd.in/e3Rtu9Ts

On the heels of a news cycle filled with stories about disease outbreaks in Africa and the U.S., this month’s newsletter dives into the importance of new vaccine development and addressing vaccine hesitancy. Key Highlights: ? Disease Spotlight: Our progress in developing vaccines for Sudan Ebolavirus and Marburg ? Understanding Sudan Ebolavirus and Marburg: Learn more about these diseases, both of which can have an average fatality rate of over 85% ? Measles Resurgence: Dr. Paul Offit’s warning on complacency and vaccine hesitancy ? How Vaccines Protect You and Your Loved Ones: A primer on the groups who benefit the most from vaccines and why